Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.960
-0.220 (-6.92%)
Oct 30, 2026, 4:00 PM EDT - Market closed
IMDX Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, IMDX stock has a consensus rating of "Buy" and an average price target of $8.25. The average 1-year stock price forecast is 178.72% higher than the current stock price, while the lowest is $4.00 (+35.14%) and the highest is $12 (+305.41%).
Price Target: $8.25 (+178.72%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 24, 2026.
Analyst Ratings
The average analyst rating for IMDX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 21, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $8 | Buy | Initiates | $8 | +170.27% | Aug 24, 2026 |
| Lake Street | Lake Street | Buy Maintains $12 | Buy | Maintains | $12 | +305.41% | Aug 18, 2026 |
| Needham | Needham | Buy Reiterates $9 | Buy | Reiterates | $9 | +204.05% | Aug 18, 2026 |
Financial Forecast
Revenue This Year
966.20K
from 4.05M
Decreased by -76.17%
Revenue Next Year
6.66M
from 966.20K
Increased by 589.53%
EPS This Year
-0.93
EPS Next Year
-0.80
from -0.93
EPS and Forward PE are based on non-GAAP adjusted numbers.